May 26, 2023–Bulletin from the annual general meeting on 26 May 2023 in Chosa Oncology AB (regulatory)May 25, 2023–CHOSA Oncology AB presents clinical phase 2 results of LiPlaCis and its Drug Response Predictor test at ASCO 2023 (regulatory)May 16, 2023–CHOSA Oncology AB out-license clinical-stage cancer vaccine candidate to Magle Group (regulatory)
